---
title: DEGRO guideline for personalized radiotherapy of brain metastases and leptomeningeal
  carcinomatosis in patients with breast cancer
date: '2024-03-15'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38488902/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240316180700&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSION AND RECOMMENDATIONS: Despite the fact that the biological
  subtype of breast cancer influences both the occurrence and relapse patterns of
  breast cancer brain metastases (BCBM), for most scenarios, no specific recommendations
  regarding radiotherapy can be made based on the existing evidence. For a limited
  number of BCBM (1-4), stereotactic radiosurgery (SRS) or fractionated stereotactic
  radiotherapy (SRT) is generally recommended irrespective of molecular subtype and
  concurrent/planned... ...'
disable_comments: true
---
CONCLUSION AND RECOMMENDATIONS: Despite the fact that the biological subtype of breast cancer influences both the occurrence and relapse patterns of breast cancer brain metastases (BCBM), for most scenarios, no specific recommendations regarding radiotherapy can be made based on the existing evidence. For a limited number of BCBM (1-4), stereotactic radiosurgery (SRS) or fractionated stereotactic radiotherapy (SRT) is generally recommended irrespective of molecular subtype and concurrent/planned... ...